| Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy. | Journal of the American Society of Nephrology | 9 hours | save | bookmark |  |  |  |
| ZESTORETIC (Lisinopril And Hydrochlorothiazide) Tablet [AstraZeneca Pharmaceuticals LP] | DailyMed Drug Label Updates | 15 hours | save | bookmark | |  |  |
| ALLHAT Investigators Report 10-Year Follow-up and Stand by Diuretics as First-Step Antihypertensive Treatment | Medscape | 2 days | save | bookmark | |  |  |
| The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment: Role of the renin angiotensin system inhibition. | BMC Geriatrics | 3 days | save | bookmark |  |  |  |
| Atrial Fibrillation at Baseline and During Follow-Up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial) | Journal of the American College of Cardiology | 3 days | save | bookmark |  |  |  |
| Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes | Holthöfer, H. (Citations) | 8 days | save | bookmark | |  |  |
| LISINOPRIL AND HYDROCHLOROTHIAZIDEtablet [Sandoz Inc] | DailyMed Drug Label Updates | 10 days | save | bookmark | |  |  |
| Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes | American Journal of Physiology: Renal Physiology | 22 days | save | bookmark |  |  |  |
| LISINOPRIL AND HYDROCHLOROTHIAZIDEtablet [Apotex Corp.] | DailyMed Drug Label Updates | 30 days | save | bookmark | |  |  |
| LISINOPRIL AND HYDROCHLOROTHIAZIDEtablet [Physicians Total Care, Inc.] | DailyMed Drug Label Updates | 30 days | save | bookmark | |  |  |
| The effect of exenatide on lisinopril pharmacodynamics and pharmacokinetics in patients with hypertension. | International Journal of Clinical Pharmacology and Therapeutics | 31 days | save | bookmark |  |  |  |
| Lisinopril/nicorandil overdose: Hypotension and ECG changes treated with metaraminol and norepinephrine: case report | Reactions | 33 days | save | bookmark |  |  |  |
| Decreasing risk of death by 80% at the cost of $12 per month | Clinical Cases and Images | 48 days | save | bookmark | |  |  |
| 2 Low-Cost Drugs May Prevent Strokes | Hearty Life, A | 49 days | save | bookmark | |  |  |
| HIT –KP HealthConnect from Kaiser Permanente Utilized to Identify and Cut Stroke/Heart Attacks | Medical Quack, The | 50 days | save | bookmark | |  |  |
| Hyperkalemia-Induced Paralysis | Pharmacotherapy | 52 days | save | bookmark |  |  |  |
| BNP at discharge in acute heart failure patients: Is it all about volemia? A study using impedance cardiography to assess fluid and hemodynamic status. | International Journal of Cardiology | 77 days | save | bookmark |  |  |  |
| Tubular and Glomerular Injury in Diabetes and the Impact of ACE Inhibition | Diabetes Care | 84 days | save | bookmark |  |  |  |
| West Virginia Most Medicated | Hearty Life, A | 91 days | save | bookmark | |  |  |
| Drug Used For High Blood Pressure Shows Benefits In Treating MS-like Disease In Mice | Medical News Today | 93 days | save | bookmark | |  |  |
| Health News of the Day | Clinical Cases and Images | 95 days | save | bookmark | |  |  |
| Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species | Nephrology Dialysis Transplantation | 96 days | save | bookmark |  |  |  |
| LISINOPRIL AND HYDROCHLOROTHIAZIDEtablet [IVAX Pharmaceuticals, Inc.] | DailyMed Drug Label Updates | 106 days | save | bookmark | |  |  |
| Dual ACE-inhibition and AT1 receptor antagonism improves ventricular lusitropy without affecting cardiac fibrosis in the congenic mRen2.Lewis rat | Therapeutic Advances in Cardiovascular Disease | 116 days | save | bookmark |  |  |  |
| Centrally active ACE inhibitors may protect against dementia | Doctor's Channel [Video] | 127 days | save | bookmark | |  |  |
| A Doctor Reclaims His Health with Superior Diet | Disease Proof | 134 days | save | bookmark | |  |  |
| LISINOPRIL AND HYDROCHLOROTHIAZIDEtablet [Mylan Pharmaceuticals Inc.] | DailyMed Drug Label Updates | 135 days | save | bookmark | |  |  |
| Pleural effusions, water balance mediators and the influence of lisinopril after completion Fontan procedures | European Journal of Cardio-Thoracic Surgery | 143 days | save | bookmark |  |  |  |
| Portal pressure responses and angiotensin peptide production in rat liver are determined by relative activity of ACE and ACE2 | American Journal of Physiology: Gastrointestinal and Liver Physiology | 148 days | save | bookmark |  |  |  |
| More patients across the world lowering 'bad' cholesterol – Further Marketing for Statins? | Medical Quack, The | 150 days | save | bookmark | |  |  |
| Lisinopril/lithium interaction: Lithium toxicity: case report | Reactions | 152 days | save | bookmark |  |  |  |
| LISINOPRIL AND HYDROCHLOROTHIAZIDEtablet [TEVA PHARMACEUTICALS USA] | DailyMed Drug Label Updates | 156 days | save | bookmark | |  |  |
| Lisinopril: Angioedema: case report | Reactions | 158 days | save | bookmark |  |  |  |
| Tubular and glomerular injury in diabetes and the impact of ACE inhibition | Diabetes Care (PAP Articles) | 168 days | save | bookmark |  |  |  |
| Automated drug screening with contractile muscle tissue engineered from dystrophic myoblasts. | FASEB Journal | 171 days | save | bookmark |  |  |  |
| SPECIAL ARTICLE: ALLHAT Findings Revisited in the Context of Subsequent Analyses, Other Trials, and Meta-analyses | Archives of Internal Medicine | 193 days | save | bookmark |  |  |  |
| Cotrimoxazole/lisinopril: Hyperkalaemia leading to ventricular arrhythmia in an elderly patient: case report | Reactions | 195 days | save | bookmark |  |  |  |
| The Impact of Migraine and the Effect of Migraine Treatment on Workplace Productivity in the United States and Suggestions for Future Research | Mayo Clinic Proceedings | 204 days | save | bookmark |  |  |  |
| Nebivolol: A third-generation beta-blocker for hypertension. | Clinical Therapeutics | 207 days | save | bookmark |  |  |  |
| Lisinopril/perindopril/ramipril: Anaphylaxis in patients receiving haemodialysis with ST-AN69 membranes: 4 case reports | Reactions | 209 days | save | bookmark |  |  |  |
| Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial | Diabetologia | 384 days | save | bookmark |  |  |  |
| Valsartan in combination with lisinopril versus the respective high dose monotherapies in hypertensive patients with microalbuminuria: the VALERIA trial | Nieminen, M.S. (Citations) | 414 days | save | bookmark | |  |  |
| Efficacy of combined antihypertensive treatment with amlodipin and lisinopril in metabolic syndrome | Nieminen, M.S. (Citations) | 519 days | save | bookmark | |  |  |
| Pulse pressure lowering effect of dual blockade with candesartan and lisinopril vs. high-dose ACE inhibition in hypertensive type 2 diabetic subjects: A CALM II study post-hoc analysis | Tuomilehto, J. (Citations) | 638 days | save | bookmark | |  |  |
| Multivariate chemometric approach to thermal solid-state FT-IR monitoring of pharmaceutical drug compound. | Journal of Pharmaceutical Sciences | 703 days | save | bookmark |  |  |  |
| A comparison of the tolerability of the direct renin inhibitor aliskiren and lisinopril in patients with severe hypertension | Journal of Human Hypertension | 905 days | save | bookmark |  |  |  |
| |  | |